| pubmed-article:18379357 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18379357 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18379357 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
| pubmed-article:18379357 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:18379357 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:18379357 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:18379357 | lifeskim:mentions | umls-concept:C1384659 | lld:lifeskim |
| pubmed-article:18379357 | lifeskim:mentions | umls-concept:C1628324 | lld:lifeskim |
| pubmed-article:18379357 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:18379357 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18379357 | pubmed:dateCreated | 2008-4-1 | lld:pubmed |
| pubmed-article:18379357 | pubmed:abstractText | Vandetanib (ZACTIMA) is a once-daily, oral anticancer drug that selectively inhibits vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) signaling. Vandetanib was evaluated as a monotherapy in a randomized, double-blind, dose-finding study in Japan. | lld:pubmed |
| pubmed-article:18379357 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18379357 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379357 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18379357 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379357 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379357 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379357 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379357 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18379357 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18379357 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:18379357 | pubmed:issn | 1556-1380 | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:KiuraKatsuyuk... | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:FukuokaMasahi... | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:NakagawaKazuh... | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:SaijoNagahiro... | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:OheYuichiroY | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:EguchiKenjiK | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:NishioKazutoK | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:TsuboiMasahir... | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:SetoTakashiT | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:YamamotoNobuy... | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:YokotaSoichir... | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:ShinkaiTetsuT | lld:pubmed |
| pubmed-article:18379357 | pubmed:author | pubmed-author:JiangHaiyiH | lld:pubmed |
| pubmed-article:18379357 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18379357 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:18379357 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18379357 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18379357 | pubmed:pagination | 386-93 | lld:pubmed |
| pubmed-article:18379357 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:meshHeading | pubmed-meshheading:18379357... | lld:pubmed |
| pubmed-article:18379357 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18379357 | pubmed:articleTitle | A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer. | lld:pubmed |
| pubmed-article:18379357 | pubmed:affiliation | Okayama Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital, Okayama, Japan. kkiura@md.okayama-u.ac.jp | lld:pubmed |
| pubmed-article:18379357 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18379357 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18379357 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18379357 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18379357 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| entrez-gene:1956 | entrezgene:pubmed | pubmed-article:18379357 | lld:entrezgene |
| entrez-gene:3791 | entrezgene:pubmed | pubmed-article:18379357 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18379357 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18379357 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379357 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379357 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379357 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379357 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379357 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379357 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379357 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18379357 | lld:pubmed |
